These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36534022)

  • 41. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
    Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
    Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study.
    Dake MD; Scheinert D; Tepe G; Tessarek J; Fanelli F; Bosiers M; Ruhlmann C; Kavteladze Z; Lottes AE; Ragheb AO; Zeller T;
    J Endovasc Ther; 2011 Oct; 18(5):613-23. PubMed ID: 21992630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value.
    Gray WA; Soga Y; Fujihara M; Iida O; Babaev A; Kawasaki D; Zeller T; O'Connor D; Jaff MR; Chavez AM; Müller-Hülsbeck S
    J Comp Eff Res; 2024 Jun; 13(6):e240025. PubMed ID: 38606556
    [No Abstract]   [Full Text] [Related]  

  • 45. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bare Metal Versus Paclitaxel-Eluting Stents for Long Femoropopliteal Lesions: Prospective Cohorts Comparison Using a Propensity Score-Matched Analysis.
    Vent PA; Kaladji A; Davaine JM; Guyomarch B; Chaillou P; Costargent A; Quillard T; Gouëffic Y
    Ann Vasc Surg; 2017 Aug; 43():166-175. PubMed ID: 28300676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease.
    Haine A; Schmid MJ; Schindewolf M; Lenz A; Bernhard SM; Drexel H; Baumgartner I; Dopheide JF
    Eur J Vasc Endovasc Surg; 2019 Dec; 58(6):865-873. PubMed ID: 31668949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atheromatous occlusive lesions of the popliteal artery treated with stent grafts: predictive factors of midterm patency.
    Peidro J; Boufi M; Loundou Dieudonné A; Hartung O; Dona B; Vernet F; Alimi Y
    Ann Vasc Surg; 2015; 29(4):708-15. PubMed ID: 25595105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arterial Preparation by Longitudinal Micro-Incisions Before Balloon Angioplasty of the Superficial Femoral and Popliteal Artery: Acute and 12-Month Results.
    Dexpert JB; Hayoz D; Engelberger RP; Krieger C; Meyer MR; Périard D
    J Endovasc Ther; 2022 Jun; 29(3):420-426. PubMed ID: 34779310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
    Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
    JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of SFA lesion treatment with Zilver PTX in diabetics vs. non-diabetics: 2-year clinical and functional results.
    Oberto S; Cetta F; Trabattoni P; Zoli S; Tavano D; Rossi F; Clerici G; Airoldi F; Spirito R; Losa S
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):565-573. PubMed ID: 25791358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trans-popliteal hybrid retrograde technique for revascularization of chronic total occlusions of the superficial femoral artery.
    García-Domínguez LJ; Falcón M; Ribé L; Hernández A; Miralles M
    Vascular; 2021 Aug; 29(4):582-588. PubMed ID: 33086943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesion.
    Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Yokoi H; Uematsu M;
    J Vasc Surg; 2016 Dec; 64(6):1691-1695.e1. PubMed ID: 27575807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comparison of Contemporary Clinical Outcomes Following Femoro-Popliteal Plain Balloon Angioplasty and Bypass Surgery for Chronic Limb Threatening Ischemia.
    Meecham L; Popplewell MA; Bate GR; Patel S; Bradbury AW
    Vasc Endovascular Surg; 2021 Aug; 55(6):544-550. PubMed ID: 33882737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years.
    Stavroulakis K; Torsello G; Manal A; Schwindt A; Hericks C; Stachmann A; Schönefeld E; Bisdas T
    J Vasc Surg; 2016 Dec; 64(6):1696-1702. PubMed ID: 27575816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry.
    Kum S; Ipema J; Chun-Yin DH; Lim DM; Tan YK; Varcoe RL; Hazenberg CEVB; Ünlü Ç
    J Endovasc Ther; 2020 Aug; 27(4):616-622. PubMed ID: 32469296
    [No Abstract]   [Full Text] [Related]  

  • 59. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Dake MD; Ansel GM; Jaff MR; Ohki T; Saxon RR; Smouse HB; Machan LS; Snyder SA; O'Leary EE; Ragheb AO; Zeller T;
    Circulation; 2016 Apr; 133(15):1472-83; discussion 1483. PubMed ID: 26969758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
    Gouëffic Y; Torsello G; Zeller T; Esposito G; Vermassen F; Hausegger KA; Tepe G; Thieme M; Gschwandtner M; Kahlberg A; Schindewolf M; Sapoval M; Diaz-Cartelle J; Stavroulakis K;
    Circulation; 2022 Nov; 146(21):1564-1576. PubMed ID: 36254728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.